Carregant...
Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
SIMPLE SUMMARY: Selective killing of cancer cells is privileged mainstream in cancer treatment and targeted therapy represents the new tool with a potential to pursue this aim. It can also aid to overcome resistance of conventional chemo- or radio-therapy. Common mutations of cancer cells (defective...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918546/ https://ncbi.nlm.nih.gov/pubmed/33672884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040795 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|